Page 2 - The Smart Investor News

Piramal Pharma soars 15% in weak market on huge volume post Q2 results

With H2 typically stronger than H1, Piramal Pharma's management said it is well-positioned to deliver a strong FY performance, supported by healthy order book and encouraging customer engagement.

United Breweries surges 15% as premiumisation drives Q2 PAT higher by 190%

United Breweries witnessed a 480 bps margin expansion to 11.9 per cent, reflecting strong operating leverage and disciplined cost management.

L&T surges 6%, sees sharpest intraday rally in 6 months on strong Q2 show

L&T delivered healthy revenue growth and record order inflows, with the ₹8.5 trillion order book at the end of September quarter providing robust multi-year revenue visibility.

Maruti dips marginally post Q2 amid cost pressures; analysts remain bullish

While concerns around margin trajectory remain, analysts largely retained a positive outlook over the medium term, driven by strong domestic demand and balance sheet strength.

BSE, Lenskart: Motilal Oswal stock ideas across large-, mid- and small-caps

Analysts at Motilal Oswal Wealth Management Research Desk are bullish on mid-caps Indian Hotels and Lenskart, and small-caps Symbiotec Pharmalab and Urban Company.

Business Standard Smart Investor Arena 2026 | Day 3

Investment experts and market veterans share perspectives on mutual funds, IPOs, wealth creation and financial independence to help investors make informed decisions. >

Know your risks, diversify, & skip tips: Lessons from Smart Investor Arena

At the BFSI Insight Summit 2026's Smart Investor Arena, experts urged investors to set financial goals, diversify portfolios, avoid herd mentality and understand risks before investing

GenZ's lifestyle spends more risky than market volatility: Sakchi Jain

At the Business Standard Smart Investor Arena, Sakchi Jain warned that Gen Z's rising reliance on credit and lifestyle spending poses a bigger threat to SIP discipline than market volatility

Building Wealth Beyond the Market Cycle: The Viren Punjabi Story

.

Ankur Warikoo | The psychology of money: Learn to earn, spend & invest

Money isn't just about getting rich; it's about gaining the freedom to live life on your own terms, author, creator, and entrepreneur Ankur Warikoo told Puneet Wadhwa at the Business Standard BFSI Ins

Laurus Labs rallies 4% for 2nd straight day; stock hits new high

FPIs increased stake in Laurus to 30.8% in the September 2026 quarter from 28% at the end of June 2026 quarter, shareholding data shows.

Bharti Airtel share price up 3%; rallies 12% in October, outperforms market

With expectations of a tariff hike soon after Jio's IPO, Motilal Oswal Financial Services expects strong earnings delivery, which could also lead to potential multiple re-rating for Bharti and JPL.

Hindustan Unilever slips 3%, hits over 6-year low ahead of Q2 results

Analysts expect HUL to report double-digit revenue driven by price hikes and anticipate pricing growth to impact volume growth, with volume growth likely to be close to mid-single digits.

Sona BLW Precision zooms 9%; stock hits new high on record Q2 earnings

Sona BLW Precision Forgings recorded its highest-ever Revenue, EBITDA, PAT, Battery Electric Vehicle (BEV) Revenue and BEV revenue share in Q2, the company said in a BSE filing.

Ather Energy extends rally, EV stock surges 20% in 2 days; here's why

Ather Energy: Overall, the outlook is positive, with volume growth, Konarc's market acceptance and sustained profitability being the key triggers to watch, say analysts at ICICI Securities.

GRSE, BEL: Defence stocks zoom up to 9% on DAC nod to ₹2.12 trn proposals

Twenty-one of the 22 Nifty India Defence constituents traded green in early trade today, driving the sectoral index 2.8 per cent higher to 8,908.

Dalmia Bharat shares dive 6% to hit 52-week low on Q2 loss of ₹205 crore

Dalmia Bharat reported a loss of ₹205 crore in Q2FY27, compared with a profit of ₹239 crore in the corresponding quarter a year ago.

Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat

Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts.

Tata Consumer Products gains 4% after Q2 show; margin recovery keenly eyed

Tata Consumer Products share price: JM Financial analysts also expect margin delivery to improve, with full benefits of the price hikes in tea and salt to be seen in Q3FY27.

Business Standard Smart Investor Arena 2026 | Day 2

Market leaders, investment experts and financial creators discuss investing strategies, global markets, wealth management and the evolving financial priorities of Indian investors. > >